Indian drug maker Sun to buy troubled peer Ranbaxy for $4.0 blnTop Indian drug giant Sun Pharmaceutical Industries said Monday it had agreed to buy its troubled peer Ranbaxy for $4.0 billion in stock, ending its ill-fated six-year control by Japan's Daiichi Sankyo.
Careless surgery brings child to disabilityFor 10 y.o. Damira Esskendirova a simple surgery instead of brining relief turned into a constant pain and possible permanent disability due to the doctor’s carelessness.
What is the cause of sleep syndrome in Kalachi?A team of finest ecologists, virologists and toxicologists arrived to the Kalachi village of Akmola Oblast to determine the cause of the mysterious sleep syndrome that has affected more than 30 villagers.